Six-month smartwatch-based atrial fibrillation (AF) screening improves detection of new-onset AF among patients at elevated stroke risk.

A new trial suggests Apple Watch could make a meaningful difference in what happens after atrial fibrillation ablation, not ...

The Apple Watch has plenty of potential for health monitoring even after discovery of a condition, and a new study outlines ...

The Supraventricular Tachycardia market benefits from aging populations, technological advances like catheter ablation, rising cardiovascular awareness, and wearable diagnostics. Growth is supported ...

Stroke Prevention 2.0 focuses on early detection of hidden risks like atrial fibrillation, inflammation, and structural heart defects.

Cytokinetics is committed to supporting patients with MYQORZO & You™, a personalized program for patients prescribed MYQORZO ...

First-of-its-kind, rotation-free single-shot PFA catheter supported by strong safety and efficacy data adds to the groundbreaking Affera family of ...

A recent review concluded that artificial intelligence (AI) is revolutionising cardiology by transforming clinical practice.

Dr Emma Svennberg, cardiologist in Stockholm and first author of the consensus paper, noted that modern AF care requires a more streamlined and holistic approach. She highlighted the need to address ...

The MarketWatch News Department was not involved in the creation of this content. SAN DIEGO, Jan. 6, 2026 /PRNewswire/ -- HUYABIO International today announced favorable Phase 1 clinical data for ...

MYQORZO is indicated for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms. MYQORZO is contraindicated with ...